Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04533945 · ClinicalTrials.gov registry record · NA
Feasibility of Using the CGM During TOC From in Persons With T2D Using Insulin
A NA study, sponsored by Northwell Health.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT04533945 is a NA study that has completed, run by Northwell Health. The registered enrollment target is 40 participants.
The verdict
NCT04533945, a NA study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Using the Libre during the TOC with persons with T2D will improve patient glucose monitoring and satisfaction, which can potentially lead to an improvement in glycemic control and hospital utilization. This study aims to assess this with inpatients using insulin.
Interventions
- DEVICE FreeStyle Libre
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-03-25 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04533945
The ClinicalTrials.gov registry entry for NCT04533945 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FreeStyle Libre is the first listed.
NCT04533945 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04533945 about?
NCT04533945 is a clinical study titled "Feasibility of Using the CGM During TOC From in Persons With T2D Using Insulin". Using the Libre during the TOC with persons with T2D will improve patient glucose monitoring and satisfaction, which can potentially lead to an improvement in glycemic control and hospital utilization. This study aims to assess this with inpatients using insulin.
What is the current status of trial NCT04533945?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2020-03-25. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT04533945?
The interventions under investigation include: FreeStyle Libre (DEVICE).
Who is sponsoring clinical trial NCT04533945?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.